Focal Point healthcare

Raising $5million initial TI for 240 bed detox facility S. Florida, building purchased - high return on investment - $100million annually

Facebook Twitter LinkedIn

According to a report published by the National Center for Drug Abuse Statistics in July 2024, 17.1% of the U.S. population had a substance abuse disorder during the past year, including 28.9 million people who had an alcohol abuse disorder and 27.2 million people who had a drug abuse disorder. However, only 14.6% received substance abuse treatment in the past year, leaving 85.4% untreated.
 
Focal Point Recovery’s mission is to address this shortfall by building state-of-the-art residential drug and alcohol rehabilitation centers. Our Managing Director, Warren Boyd and Executive Staff, have extensive experience owning and operating drug and alcohol treatment facilities, including currently managing facilities in California and Texas. 
 
We acquired a building in southern Florida that was most recently operated as an office building but was originally built as a hospital and continues to have clinical hospital zoning. Focal Point founding members have contributed $5 million to convert this building into a 240 bed clinically licensed detox-residential drug and alcohol treatment facility. We’re seeking qualified investors to contribute an additional $5 million.
 
The investment returns outlined in the enclosed prospectus are derived from the Stage 1 build-out to accommodate 48 patients.  However, we plan to expand this facility to its maximum capacity of 240 beds and then sell it within the next 5 years. When fully built out and stabilized, revenues are projected to exceed $8,000,000/month. Since operating expenses typically run between 40-45% of gross revenue, the ROE is expected to exceed 50%.
 
We’re offering qualified investors the opportunity to receive 40% of the annual net income plus 20% of the proceeds from the final sale of this facility in exchange for a $5 million investment ($100,000 minimum investment).
 
This is a unique opportunity to help people battling substance addiction while earning a high rate of return on your investment.  We secured $500,000 of equity funding during the first few days of this offering, therefore interested investors should contact me as soon as possible.   
 
Thank you for your consideration, and I look forward to speaking soon.
 
Regards,
 
Glenn Burkhardt
Director, Investor Relations





Ready to Ask For Funding for your company?

Post a Funding Request

Focal Point healthcare is no longer seeking funding.